Read the Guidance which is confirmed.. This is not Debenhams!4 Feb 2020 11:48
The underlying guidance for 2019 has been upgraded to reflect the impact of the JV, as well as consolidation of Boston IVF.
2019 revenues guidance: USD 2,500-2,540m (previous guidance: USD 2,425-2,465m)
2019 EBITDA guidance: USD 575-585m (previous guidance: USD 566-576m)
2019 share of profits from associate guidance: USD 7m
2019 net income to equity holders guidance: USD 320-330m